Skip to main content

Aurobindo Pharma

Aurobindo Pharma Ltd is an Indian pharmaceutical manufacturing company engaged in the research, development, production, and commercialization of generic pharmaceuticals and active pharmaceutical ingredients. The company manufactures generic oral solids, sterile injectables, antiretrovirals, cardiovascular drugs, central nervous system treatments, and active ingredients across multiple therapeutic areas. Its commercial operations cover major regulated international healthcare markets including the United States, Europe, and emerging economies. Principal revenue is derived from direct commercial sales of finished generic formulations to hospital networks, retail pharmacy chains, and global healthcare distributors, alongside exports of active ingredients. Aurobindo Pharma is one of the largest generic pharmaceutical manufacturers in India, recognized for its extensive vertical manufacturing integration. Headquartered in Hyderabad, India, the company's common stock is publicly listed and traded on the National Stock Exchange of India and BSE under the ticker AUROPHARMA.

18 of the funds FundTelligence covers report a position in Aurobindo Pharma.

Legal name
Aurobindo Pharma Ltd.
Sector
Health Care
Country
India
Funds holding it
18

Funds holding Aurobindo Pharma

Showing the 8 largest of 18 funds holding it.

Loading...